Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.
Disrupted sleep schedules may change breast tissue and immune function, helping aggressive breast cancer grow faster.
Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...
Working the night shift, frequently flying across time zones or keeping an irregular sleep schedule does more than just leave ...
Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...
Spanish researchers have created a powerful new open-source tool that helps uncover the hidden genetic networks driving ...
More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
News-Medical.Net on MSN
How diabetes medications may influence cancer risk and progression
Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results